BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7956947)

  • 61. Prostate cancer induces C/EBPβ expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome.
    Adamo H; Hammarsten P; Hägglöf C; Dahl Scherdin T; Egevad L; Stattin P; Halin Bergström S; Bergh A
    Prostate; 2019 Apr; 79(5):435-445. PubMed ID: 30536410
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transforming growth factor-beta in benign and malignant prostate.
    Lee C; Sintich SM; Mathews EP; Shah AH; Kundu SD; Perry KT; Cho JS; Ilio KY; Cronauer MV; Janulis L; Sensibar JA
    Prostate; 1999 Jun; 39(4):285-90. PubMed ID: 10344218
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of platelet-derived growth factor and transforming growth factor and their correlation with cellular morphology in glial tumors.
    Mapstone TB
    J Neurosurg; 1991 Sep; 75(3):447-51. PubMed ID: 1651380
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival.
    Friess H; Yamanaka Y; Büchler M; Ebert M; Beger HG; Gold LI; Korc M
    Gastroenterology; 1993 Dec; 105(6):1846-56. PubMed ID: 8253361
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression of ras proto-oncogenes in the Dunning R3327 rat prostatic adenocarcinoma system.
    Cooke DB; Quarmby VE; Petrusz P; Mickey DD; Der CJ; Isaacs JT; French FS
    Prostate; 1988; 13(4):273-87. PubMed ID: 3064050
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study.
    Truong LD; Kadmon D; McCune BK; Flanders KC; Scardino PT; Thompson TC
    Hum Pathol; 1993 Jan; 24(1):4-9. PubMed ID: 7678092
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Production and significance of TGF-beta in AT-3 metastatic cell line established from the Dunning rat prostatic adenocarcinoma.
    Matuo Y; Nishi N; Takasuka H; Masuda Y; Nishikawa K; Isaacs JT; Adams PS; McKeehan WL; Sato GH
    Biochem Biophys Res Commun; 1990 Jan; 166(2):840-7. PubMed ID: 2302241
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transforming growth factor beta (TGF-beta) expression in isolated and cultured rat hepatocytes.
    Gao C; Gressner G; Zoremba M; Gressner AM
    J Cell Physiol; 1996 Jun; 167(3):394-405. PubMed ID: 8655593
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Extracellular Vesicles from Metastatic Rat Prostate Tumors Prime the Normal Prostate Tissue to Facilitate Tumor Growth.
    Halin Bergström S; Hägglöf C; Thysell E; Bergh A; Wikström P; Lundholm M
    Sci Rep; 2016 Aug; 6():31805. PubMed ID: 27550147
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cell type-specific expression of transforming growth factor-beta 1 in the mouse uterus during the periimplantation period.
    Tamada H; McMaster MT; Flanders KC; Andrews GK; Dey SK
    Mol Endocrinol; 1990 Jul; 4(7):965-72. PubMed ID: 2284009
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Localization of transforming growth factor beta isoforms in the normal murine small intestine and colon.
    Barnard JA; Warwick GJ; Gold LI
    Gastroenterology; 1993 Jul; 105(1):67-73. PubMed ID: 8514063
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression of a transfected v-Harvey-ras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability.
    Treiger B; Isaacs J
    J Urol; 1988 Dec; 140(6):1580-6. PubMed ID: 3057238
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts.
    Zhao H; Peehl DM
    Prostate; 2009 Jun; 69(9):991-1000. PubMed ID: 19267366
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An autocrine motility factor secreted by the Dunning R-3327 rat prostatic adenocarcinoma cell subtype AT2.1.
    Evans CP; Walsh DS; Kohn EC
    Int J Cancer; 1991 Aug; 49(1):109-13. PubMed ID: 1874563
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Aberrant TGF-beta production and regulation in metastatic malignancy.
    Schwarz LC; Wright JA; Gingras MC; Kondaiah P; Danielpour D; Pimentel M; Sporn MB; Greenberg AH
    Growth Factors; 1990; 3(2):115-27. PubMed ID: 2169772
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CORRELATION OF EXPRESSION OF TGF- β AND MMP2 BETWEEN PROSTATIC ADENOCARCINOMA AND ADJACENT UNAFFECTED PARENCHYMA.
    Mašić S; Bacalja J; Vučić M; Čupić H; Tomas D; Ulamec M; Spajić B; Skenderi F; Krušlin B
    Acta Clin Croat; 2022 Oct; 61(Suppl 3):9-14. PubMed ID: 36938549
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The loss of E-cadherin mRNA transcripts in rat prostatic tumors is accompanied by increased expression of mRNA transcripts encoding fibronectin and its receptor.
    MacCalman CD; Brodt P; Doublet JD; Jednak R; Elhilali MM; Bazinet M; Blaschuk OW
    Clin Exp Metastasis; 1994 Mar; 12(2):101-7. PubMed ID: 8306523
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but not in the highly differentiated Dunning R3327 prostatic adenocarcinoma.
    Westin P; Bergh A; Damber JE
    Prostate; 1993; 22(1):65-74. PubMed ID: 8426839
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oncogene expression in prostate cancer: Dunning R3327 rat dorsal prostatic adenocarcinoma system.
    Cooke DB; Quarmby VE; Mickey DD; Isaacs JT; French FS
    Prostate; 1988; 13(4):263-72. PubMed ID: 3217275
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Induction of transforming growth factor beta in hormonally treated human prostate cancer.
    Muir GH; Butta A; Shearer RJ; Fisher C; Dearnaley DP; Flanders KC; Sporn MB; Colletta AA
    Br J Cancer; 1994 Jan; 69(1):130-4. PubMed ID: 8286194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.